Explore how LH-RH analogues work as a biochemical 'off-switch' in advanced prostate cancer treatment through clinical evaluation and research findings.
Discover how 2-amino-5-arylmethyl-1,3-thiazole derivatives show promise as potential therapeutic agents for prostate cancer treatment.
How scientists are using revolutionary 'click chemistry' to build precision gene therapies that hunt down prostate cancer cells.
Discover how 68Ga/177Lu-PSMA I&T is transforming prostate cancer treatment through theranostics, combining precise diagnosis with targeted therapy.
Discover how a groundbreaking serum proteomics approach is revolutionizing prostate cancer diagnosis, moving beyond PSA tests to precise multi-protein signatures.
Discover how [(18)F]YC-88, a revolutionary PSMA-targeting radiotracer, provides unprecedented clarity in prostate cancer detection with rapid clearance from healthy tissues.
Exploring drug repurposing strategies targeting M2 macrophages in castration-resistant prostate cancer bone metastases through transcriptomics and network analysis.
Discover how 99mTc-labelled low molecular weight inhibitors are transforming prostate cancer detection through precise PSMA targeting and SPECT imaging.